
Sign up to save your podcasts
Or
Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.2
621621 ratings
Plus: American Express shares fell after its outlook for the year disappointed investors. Verizon stock rose after beating Wall Street expectations. And Novo Nordisk surged after positive results from a clinical trial of an experimental weight loss drug. Danny Lewis reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
1,636 Listeners
4,326 Listeners
1,755 Listeners
446 Listeners
192 Listeners
2,790 Listeners
1,434 Listeners
1,007 Listeners
178 Listeners
1,283 Listeners
5,897 Listeners
1,532 Listeners
189 Listeners
1,317 Listeners
566 Listeners
151 Listeners
75 Listeners
124 Listeners